Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ADD-ON THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 86 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Biraben, A; Beaussart, M; Josien, E; Pestre, M; Savet, JF; Schaff, JL; Tourniaire, D; Sevestre, M; Renault-Djouadi, J
      Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study

      EPILEPTIC DISORDERS
    2. Pledger, G
      Proof of efficacy trials: choosing the dose

      EPILEPSY RESEARCH
    3. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
      Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)

      EPILEPSY RESEARCH
    4. Weir, MR; Weber, MA; Neutel, JM; Vendetti, J; Michelson, EL; Wang, RY
      Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: A clinical experience trial

      AMERICAN JOURNAL OF HYPERTENSION

    5. Levetiracetam - Keppra (R) - Antiepileptic

      DRUGS OF THE FUTURE
    6. Mecarelli, O; Piacenti, A; Pulitano, P; Vicenzini, E; Rizzo, C; Rinalduzzi, S; de Feo, MR; Accornero, N
      Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers

      CLINICAL NEUROPHARMACOLOGY
    7. Skodda, S; Kramer, I; Spittler, JF; Gehlen, W
      Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment

      JOURNAL OF NEUROLOGY
    8. Bauer, J; Bergmann, A; Stodieck, SRG
      Tiagabine-HCI (Gabitril((R))) as comedication in the treatment of epilepsy

      AKTUELLE NEUROLOGIE
    9. Glauser, TA
      Oxcarbazepine in the treatment of epilepsy

      PHARMACOTHERAPY
    10. Hovinga, CA
      Levetiracetam: A novel antiepileptic drug

      PHARMACOTHERAPY
    11. Shorvon, S
      Pyrrolidone derivatives

      LANCET
    12. Jallon, P; Picard, F
      Bodyweight gain and anticonvulsants - A comparative review

      DRUG SAFETY
    13. Arroyo, S; Kramer, G
      Treating epilepsy in the elderly - Safety considerations

      DRUG SAFETY
    14. Arzimanoglou, A; Kulak, I; Bidaut-Mazel, C; Baldy-Moulinier, M
      Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy.

      REVUE NEUROLOGIQUE
    15. Freiman, TM; Kukolja, J; Heinemeyer, J; Eckhardt, K; Aranda, H; Rominger, A; Dooley, DJ; Zentner, J; Feuerstein, TJ
      Modulation of K+-evoked [H-3]-noradrenaline release from rat and human brain slices by gabapentin: involvement of K-ATP channels

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    16. Reinhardt, D; von Berg, A; Lemoine, H
      Comparison of the long-term beta(2) sympathomimetics formoterol and salmeterol

      MONATSSCHRIFT KINDERHEILKUNDE
    17. Tatum, WO; French, JA; Faught, E; Morris, GL; Liporace, J; Kanner, A; Goff, SL; Winters, L; Fix, A
      Postmarketing experience with topiramate and cognition

      EPILEPSIA
    18. Crawford, P; Meinardi, H; Brown, S; Rentmeester, TW; Pedersen, B; Pedersen, PC; Lassen, LC
      Tiagabine: Efficacy and safety in adjunctive treatment of partial seizures

      EPILEPSIA
    19. Montenegro, MA; Cendes, F; Noronha, ALA; Mory, SB; Carvalho, MI; Marques, LHN; Guerreiro, CAM
      Efficacy of clobazam as add-on therapy in patients with refractory partialepilepsy

      EPILEPSIA
    20. Beran, R; Berkovic, S; Black, A; Danta, G; Dunne, J; Frasca, J; Grainger, K; Kilpatrick, C; McKenzie, R; McLaughlin, D; Schapel, G; Somerville, J
      AUStralian Study of Titration to Effect Profile of Safety (AUS-STEPS): High-dose partial gabapentin (Neurontin) in partial seizures

      EPILEPSIA
    21. Tong, X; Patsalos, PN
      A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain

      BRITISH JOURNAL OF PHARMACOLOGY
    22. Aiken, SP; Brown, WM
      Treatment of epilepsy: Existing therapies and future developments

      FRONTIERS IN BIOSCIENCE
    23. Richens, A; Mawer, G; Crawford, P; Harrison, B
      A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy

      SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    24. Chadwick, D; Smith, D; Crawford, P; Harrison, B
      Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy

      SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    25. Trinka, E; Niedermuller, U; Thaler, C; Doering, S; Moroder, T; Ladurner, G; Bauer, G
      Gabapentin-induced mood changes with hypomanic features in adults

      SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    26. Betts, T; Waegemans, T; Crawford, P
      A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy

      SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    27. Vajda, FJE
      New antiepileptic drugs

      JOURNAL OF CLINICAL NEUROSCIENCE
    28. Grant, R; Shorvon, SD
      Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy

      EPILEPSY RESEARCH
    29. Uldall, P; Bulteau, C; Pedersen, SA; Dulac, O; Lyby, K
      Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study

      EPILEPSY RESEARCH
    30. Schmidt, D; Gram, L; Brodie, M; Kramer, G; Perucca, E; Kalviainen, R; Elger, CE
      Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescribing physician

      EPILEPSY RESEARCH
    31. Conca, A; Swoboda, E; Konig, P; Koppi, S; Beraus, W; Kunz, A; Fritzsche, H; Weiss, P
      Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    32. Bourgeois, BFD
      New antiepileptic drugs in children: Which ones for which seizures?

      CLINICAL NEUROPHARMACOLOGY
    33. Wong, ICK; Lhatoo, SD
      Adverse reactions to new anticonvulsant drugs

      DRUG SAFETY
    34. Glauser, TA
      Expanding first-line therapy options for children with partial seizures

      NEUROLOGY
    35. Shorvon, SD; Lowenthal, A; Janz, D; Bielen, E; Loiseau, P
      Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures

      EPILEPSIA
    36. Sabers, A; Gram, L
      Newer anticonvulsants - Comparative review of drug interactions and adverse effects

      DRUGS
    37. Gericke, CA; Picard, F; de Saint-Martin, A; Strumia, S; Marescaux, C; Hirsch, E
      Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study

      EPILEPTIC DISORDERS
    38. Kaminski, R; Jasinski, M; Jagiello-Wojtowicz, E; Kleinrok, Z; Czuczwar, SJ
      Effect of amlodipine upon the protective activity of antiepileptic drugs against maximal electro shock-induced seizures in mice

      PHARMACOLOGICAL RESEARCH
    39. Baldassarre, JS; Pledger, GW
      Clinical trial design for new antiepileptic drugs: Determination of dose and titration schedules

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    40. Dodrill, CB; Arnett, JL; Hayes, AG; Garofalo, EA; Greeley, CA; Greiner, MJ; Pierce, MW
      Cognitive abilities and adjustment with gabapentin: results of a multisitestudy

      EPILEPSY RESEARCH
    41. Pimentel, J; Guimaraes, ML; Lima, L; Leitao, O; Sampaio, MJ
      Lamotrigine as add-on therapy in treatment-resistant epilepsy

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    42. Pellock, JM
      Managing pediatric epilepsy syndromes with new antiepileptic drugs

      PEDIATRICS
    43. Cramer, JA; Fisher, R; Ben-Menachem, E; French, J; Mattson, RH
      New antiepileptic drugs: Comparison of key clinical trials

      EPILEPSIA
    44. Dean, C; Mosier, M; Penry, K
      Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures

      EPILEPSIA
    45. Loiseau, P
      Review of controlled trials of gabitril (tiagabine): A clinician's viewpoint

      EPILEPSIA
    46. Elger, CE; Fernandez, G
      Options after the first antiepileptic drug has failed

      EPILEPSIA
    47. Bruni, J
      Gabapentin as adjunctive therapy for partial seizures

      EPILEPSIA
    48. McLean, MJ
      Gabapentin in the management of convulsive disorders

      EPILEPSIA
    49. Privitera, MD
      Evidence-based medicine and antiepileptic drugs

      EPILEPSIA
    50. Morris, GL
      Gabapentin

      EPILEPSIA
    51. Mayer, T; Schutte, W; Wolf, P; Elger, CE
      Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study

      ACTA NEUROLOGICA SCANDINAVICA
    52. EMILIEN G; MALOTEAUX JM
      PHARMACOLOGICAL MANAGEMENT OF EPILEPSY - MECHANISM OF ACTION, PHARMACOKINETIC DRUG-INTERACTIONS, AND NEW DRUG DISCOVERY POSSIBILITIES

      International journal of clinical pharmacology and therapeutics
    53. KALVIAINEN R; BRODIE MJ; DUNCAN J; CHADWICK D; EDWARDS D; LYBY K
      A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TIAGABINE GIVEN 3-TIMES DAILY AS ADD-ON THERAPY FOR REFRACTORY PARTIAL SEIZURES

      Epilepsy research
    54. OZYAZGAN S; SENSES V; UTKAN T; YILDIRAN G; ULAK G; GACAR N; OZUNER Z; AKKAN AG
      THE EFFECT OF ISRADIPINE ON MAXIMAL ELECTROSHOCK SEIZURES IN MICE

      General pharmacology
    55. KOHLER M; HOFFMANN GF
      RELEVANCE OF NEW ANTIEPILEPTICS IN PEDIAT RICS

      Klinische Padiatrie
    56. CHRYSANT SG; STIMPEL M
      ANTIHYPERTENSIVE EFFECTIVENESS OF A VERY-LOW FIXED-DOSE COMBINATION OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE

      Journal of cardiovascular pharmacology
    57. CHADWICK DW; ANHUT H; GREINER MJ; ALEXANDER J; MURRAY GH; GAROFALO EA; PIERCE MW
      A DOUBLE-BLIND TRIAL OF GABAPENTIN MONOTHERAPY FOR NEWLY-DIAGNOSED PARTIAL SEIZURES

      Neurology
    58. BROGDEN RN; WISEMAN LR
      MOEXIPRIL - A REVIEW OF ITS USE IN THE MANAGEMENT OF ESSENTIAL-HYPERTENSION

      Drugs
    59. WONG ICK; TAVERNOR SJ; TAVERNOR RME
      PSYCHIATRIC ADVERSE-EFFECTS OF ANTICONVULSANT DRUGS - INCIDENCE AND THERAPEUTIC IMPLICATIONS

      CNS DRUGS
    60. PRIVITERA MD
      TOPIRAMATE - A NEW ANTIEPILEPTIC DRUG

      The Annals of pharmacotherapy
    61. BATTINO D; CROCI D; GRANATA T; ESTIENNE M; PISANI F; AVANZINI G
      LAMOTRIGINE PLASMA-CONCENTRATIONS IN CHILDREN AND ADULTS - INFLUENCE OF AGE AND ASSOCIATED THERAPY

      Therapeutic drug monitoring
    62. BAULAC M; ARZIMANOGLOU A; SEMAH F; CAVALCANTI D
      THERAPEUTIC OPTIONS PROVIDED BY THE NEW A NTIEPILEPTIC DRUGS

      Revue neurologique
    63. BERGEY GK; MORRIS HH; ROSENFELD W; BLUME WT; PENOVICH PE; MORRELL MJ; LEIDERMAN DB; CROCKATT JG; LAMOREAUX L; GAROFALO E; PIERCE M
      GABAPENTIN MONOTHERAPY .1. AN 8-DAY, DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY IN HOSPITALIZED-PATIENTS WITH REFRACTORY COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES

      Neurology
    64. BOROWICZ KK; GASIOR M; KLEINROK Z; CZUCZWAR SJ
      INFLUENCE OF ISRADIPINE, NIGULDIPINE AND DANTROLENE ON THE ANTICONVULSIVE ACTION OF CONVENTIONAL ANTIEPILEPTICS IN MICE

      European journal of pharmacology
    65. MARSON AG; KADIR ZA; HUTTON JL; CHADWICK DW
      THE NEW ANTIEPILEPTIC DRUGS - A SYSTEMATIC REVIEW OF THEIR EFFICACY AND TOLERABILITY

      Epilepsia
    66. DECKERS CLP; HEKSTER YA; KEYSER A; MEINARDI H; RENIER WO
      REAPPRAISAL OF POLYTHERAPY IN EPILEPSY - A CRITICAL-REVIEW OF DRUG LOAD AND ADVERSE-EFFECTS

      Epilepsia
    67. SHORVON S; STEFAN H
      OVERVIEW OF THE SAFETY OF NEWER ANTIEPILEPTIC DRUGS

      Epilepsia
    68. DELEU D; HANSSENS Y
      NEW CHALLENGES IN THE TREATMENT OF EPILEPSY

      Saudi medical journal
    69. CONCA A; KOPPI S; KONIG P; SWOBODA E; KRECKE N
      TRANSCRANIAL MAGNETIC STIMULATION - A NOVEL ANTIDEPRESSIVE STRATEGY

      Neuropsychobiology
    70. GASIOR M; KAMINSKI R; BRUDNIAK T; KLEINROK Z; CZUCZWAR SJ
      INFLUENCE OF NICARDIPINE, NIMODIPINE AND FLUNARIZINE ON THE ANTICONVULSANT EFFICACY OF ANTIEPILEPTICS AGAINST PENTYLENETETRAZOL IN MICE

      Journal of neural transmission
    71. SABERS A; GRAM L
      DRUG-TREATMENT OF EPILEPSY IN THE 1990S - ACHIEVEMENTS AND NEW DEVELOPMENTS

      Drugs
    72. HOPPU K; NERGARDH AR; ERIKSSON ASE; BECK O; FORSSBLAD E; BOREUS LO
      FLUNARIZINE OF LIMITED VALUE IN CHILDREN WITH INTRACTABLE EPILEPSY

      Pediatric neurology
    73. DAILEY JW; CHEONG JH; KO KH; ADAMSCURTIS LE; JOBE PC
      ANTICONVULSANT PROPERTIES OF D-20443 IN GENETICALLY EPILEPSY-PRONE RATS - PREDICTION OF CLINICAL-RESPONSE

      Neuroscience letters
    74. HANDFORTH A; MAI T; TREIMAN DM
      RISING DOSE STUDY OF SAFETY AND TOLERANCE OF FLUNARIZINE

      European Journal of Clinical Pharmacology
    75. FISHER R; BLUM D
      CLOBAZAM, OXCARBAZEPINE, TIAGABINE, TOPIRAMATE, AND OTHER NEW ANTIEPILEPTIC DRUGS

      Epilepsia
    76. PATSALOS PN; DUNCAN JS
      NEW ANTIEPILEPTIC DRUGS - A REVIEW OF THEIR CURRENT STATUS AND CLINICAL POTENTIAL

      CNS DRUGS
    77. WAFFORD KA; BAIN CJ; QUIRK K; MCKERNAN RM; WINGROVE PB; WHITING PJ; KEMP JA
      A NOVEL ALLOSTERIC MODULATORY SITE ON THE GABA(A) RECEPTOR-BETA SUBUNIT

      Neuron
    78. POHL M; MARES P
      INFLUENCE OF FLUNARIZINE ON HIPPOCAMPAL EPILEPTIC AFTERDISCHARGES IN THE RAT

      Physiological Research
    79. LEPPIK IE
      ANTIEPILEPTIC DRUGS IN DEVELOPMENT - PROSPECTS FOR THE NEAR FUTURE

      Epilepsia
    80. BEBIN M; BLECK TP
      NEW ANTICONVULSANT DRUGS - FOCUS ON FLUNARIZINE, FOSPHENYTOIN, MIDAZOLAM AND STIRIPENTOL

      Drugs
    81. SATZINGER G
      ANTIEPILEPTICS FROM GAMMA-AMINOBUTYRIC-ACID

      Arzneimittel-Forschung
    82. PORTER RJ
      NEW DEVELOPMENTS IN THE SEARCH FOR IMPROVED ANTIEPILEPTIC DRUGS

      Japanese journal of psychiatry and neurology
    83. LEPPIK IE; GRAVES N; DEVINSKY O
      NEW ANTIEPILEPTIC MEDICATIONS

      Neurologic clinics
    84. FISHER RS
      EMERGING ANTIEPILEPTIC DRUGS

      Neurology
    85. TREIMAN DM; PLEDGER GW; DEGIORGIO C; TSAY JY; CEREGHINO JJ
      INCREASING PLASMA-CONCENTRATION TOLERABILITY STUDY OF FLUNARIZINE IN COMEDICATED EPILEPTIC PATIENTS

      Epilepsia
    86. KALVIAINEN R; KERANEN T; RIEKKINEN PJ
      PLACE OF NEWER ANTIEPILEPTIC DRUGS IN THE TREATMENT OF EPILEPSY

      Drugs


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 11:47:33